openPR Logo
Press release

Biosimilars Market (2021 To 2030) - Industry Trends, Share, Size, Growth, Opportunity And Forecast

11-26-2021 05:05 AM CET | Health & Medicine

Press release from: The Business research company

Biosimilars Market

Biosimilars Market

Get up to 33% off on ALL market research reports at The Business Research Company's holiday sale; buy now!
https://www.thebusinessresearchcompany.com/global-market-reports

‘Biosimilars Global Market Report 2021 – COVID-19 Growth And Change’ by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing this, and highlights of the opportunities that companies in the industry can take on. The market research report helps gain a truly global perspective of the biosimilars industry as it covers 60 geographies. Regional and country breakdowns give an analysis of the market in each geography, with information on the size of the market by region and by country.

The countries covered in the global biosimilars market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The regions covered in the global biosimilars market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Know What You Need? Directly Purchase The Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2807

The biosimilars market consists of sales of biosimilars and related services that are used to treat chronic diseases such as diabetes, arthritis, and cancer. Biosimilars are pharmaceuticals that are manufactured using cell lines and offer no clinical difference as compared to biologics. Biosimilars are made once the patent of biologics is expired.

The global biosimilars market is expected to grow from $7.49 billion in 2020 to $8.05 billion in 2021 at a compound annual growth rate (CAGR) of 7.5%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The biosimilars market is expected to reach $21.13 billion in 2025 at a CAGR of 27%.

Request For A Sample Of The Biosimilars Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2807&type=smp

Global biosimilars market segmentation in TBRC’s report is:
1) By Product: Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins
2) By Types: Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Others
3) By Application: Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Others

Major players in the biosimilars market are Pfizer, Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Boehringer Ingelheim, Elli Lilly and Company, Mylan N.V., Sanofi, and STADA Arzneimittel.

Need More? Read Further On The Biosimilars Market Here:
https://www.thebusinessresearchcompany.com/report/biosimilars-market-global-report

The Table of Contents includes:
1. Executive Summary
2. Biosimilars Market Characteristics
3. Biosimilars Market Trends And Strategies
4. Impact Of COVID-19 On Biosimilars
5. Biosimilars Market Size And Growth
.....
27. Biosimilars Market Competitive Landscape And Company Profiles
28. Biosimilars Pipeline Analysis
29. Key Mergers And Acquisitions In The Biosimilars Market
30. Biosimilars Market Future Outlook and Potential Analysis

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Get a glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilars Market (2021 To 2030) - Industry Trends, Share, Size, Growth, Opportunity And Forecast here

News-ID: 2475315 • Views: 220

More Releases from The Business research company

Nutritional Analysis Market (2022 to 2031) - Industry Analysis, Size, Share, Gro …
'Nutritional Analysis Global Market Report 2022 - Market Size, Trends, And Global Forecast 2022-2026' by The Business Research Company is the most comprehensive report available on this market, with analysis of the market's historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can take on. The Nutritional Analysis market research report helps gain a truly global perspective of the Nutritional
In-Flight Entertainment and Connectivity Market 2022 Trends, Growth, Size, Segme …
'In-Flight Entertainment And Connectivity Global Market Report 2022 - Market Size, Trends, And Global Forecast 2022-2026' by The Business Research Company is the most comprehensive report available on this market, with analysis of the market's historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can take on. The in-flight entertainment and connectivity market research report helps gain a truly global
Grain Alcohol Market 2022 Analysis By Top Keyplayers | Archer-Daniels-Midland Co …
'Grain Alcohol Global Market Report 2022 - Market Size, Trends, And Global Forecast 2022-2026' by The Business Research Company is the most comprehensive report available on this market, with analysis of the market's historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can take on. The Grain Alcohol market research report helps gain a truly global perspective of the Grain
Meat Processing Equipment Market To Reach $13.62 Billion, Globally, By 2026 At 6 …
Meat Processing Equipment Global Market Report 2022 - Market Size, Trends, And Global Forecast 2022-2026' by The Business Research Company is the most comprehensive report available on this market, with analysis of the market's historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can take on. The meat processing equipment market research report helps gain a truly global perspective of

All 5 Releases


More Releases for Biosimilars

Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was
Global Biosimilars Market Research Report
This report studies the global Biosimilars market status and forecast, categorizes the global Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Pfizer Sandoz International GmbH Teva Pharmaceuticals Industries Amgen Inc Biocon Dr. Reddy’s Laboratories F. Hoffmann-La Roche Celltrion Samsung Bioepis
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Biosimilar is a medicine developed on the original biological reference product. The production process of biopharmaceuticals vary from one manufacturer to another, thus every biosimilar product is unique from the other. Biosimilar manufactures use different culture conditions, master cell lines, purification techniques, and raw materials. This in turn, helps meet the rising prevalence of diabetes due to inadequate healthcare services, rising prevalence of obesity, For instance, According to 2013 American
Enbrel Biosimilars Clinical Trial Insight
“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than 5 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. Currently 5 biosimilar version of Enbrel are commercially available in Iran, Mexico, India, UK and Australia. The patent on Enbrel was originally set to expire on